The Valley Desk

ArticleEMBO molecular medicinePublished

FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma

13 of 33 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
EMBO molecular medicine
Published
Subject terms
Humans; Human T-lymphotropic virus 1; Tumor Suppressor Proteins; Transcription Factors; Prognosis; Up-Regulation; Interferon Regulatory Factors; Basic-Leucine Zipper Transcription Factors; Leukemia-Lymphoma, Adult T-Cell; Metabolomics; Biomarkers, Tumor; Tumor Protein p73
PubMed ID
42864421
PubMed Central ID
PMC13748658
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal